BARCLAYS PLC - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 56 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$67,000
+63.4%
18,157
+363.8%
0.00%
Q1 2019$41,000
+4000.0%
3,915
+3854.5%
0.00%
Q4 2018$1,000
-98.4%
99
-98.1%
0.00%
Q3 2018$63,000
+530.0%
5,254
+479.3%
0.00%
Q2 2018$10,000
-56.5%
907
-39.5%
0.00%
Q1 2018$23,000
-69.3%
1,500
-73.2%
0.00%
Q4 2017$75,0005,6000.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders